vs
纽约梅隆银行（BK）与欧加隆（OGN）财务数据对比。点击上方公司名可切换其他公司
欧加隆的季度营收约是纽约梅隆银行的1.1倍（$1.5B vs $1.3B），纽约梅隆银行净利率更高（108.5% vs -13.6%，领先122.1%），纽约梅隆银行同比增速更快（12.7% vs -5.3%），纽约梅隆银行自由现金流更多（$4.7B vs $96.0M），过去两年纽约梅隆银行的营收复合增速更高（13.8% vs -3.6%）
纽约梅隆银行是总部位于美国纽约的全球性金融服务机构，2007年7月由纽约银行与梅隆金融公司合并组建而成，业务覆盖全球众多市场，为机构、企业及个人客户提供专业金融服务，在资产管理、证券服务等领域拥有领先的行业地位。
欧加隆是一家总部位于美国新泽西州泽西城的制药企业，核心业务覆盖生殖医学、避孕、精神科、激素替代疗法及麻醉领域的药物研发与生产。公司所有产品均在美国境外生产，同时美国市场贡献了其三分之一的营收。
BK vs OGN — 直观对比
营收规模更大
OGN
是对方的1.1倍
$1.3B
营收增速更快
BK
高出18.1%
-5.3%
净利率更高
BK
高出122.1%
-13.6%
自由现金流更多
BK
多$4.7B
$96.0M
两年增速更快
BK
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.5B |
| 净利润 | $1.5B | $-205.0M |
| 毛利率 | — | 49.2% |
| 营业利润率 | — | -9.8% |
| 净利率 | 108.5% | -13.6% |
| 营收同比 | 12.7% | -5.3% |
| 净利润同比 | 26.5% | -288.1% |
| 每股收益（稀释后） | $2.01 | $-0.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BKOGN
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.2B | $1.6B | ||
| Q2 25 | $1.2B | $1.6B | ||
| Q1 25 | $1.2B | $1.5B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.0B | $1.6B | ||
| Q2 24 | $1.0B | $1.6B | ||
| Q1 24 | $1.0B | $1.6B |
净利润BKOGN
| Q4 25 | $1.5B | $-205.0M | ||
| Q3 25 | $1.4B | $160.0M | ||
| Q2 25 | $1.4B | $145.0M | ||
| Q1 25 | $1.2B | $87.0M | ||
| Q4 24 | $1.2B | $109.0M | ||
| Q3 24 | $1.2B | $359.0M | ||
| Q2 24 | $1.2B | $195.0M | ||
| Q1 24 | $1.0B | $201.0M |
毛利率BKOGN
| Q4 25 | — | 49.2% | ||
| Q3 25 | — | 53.5% | ||
| Q2 25 | — | 54.8% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 56.3% | ||
| Q3 24 | — | 58.3% | ||
| Q2 24 | — | 58.4% | ||
| Q1 24 | — | 59.0% |
营业利润率BKOGN
| Q4 25 | — | -9.8% | ||
| Q3 25 | — | 15.2% | ||
| Q2 25 | — | 14.4% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 8.1% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 14.6% | ||
| Q1 24 | — | 14.5% |
净利率BKOGN
| Q4 25 | 108.5% | -13.6% | ||
| Q3 25 | 116.9% | 10.0% | ||
| Q2 25 | 118.3% | 9.1% | ||
| Q1 25 | 105.3% | 5.8% | ||
| Q4 24 | 96.7% | 6.8% | ||
| Q3 24 | 112.8% | 22.7% | ||
| Q2 24 | 113.4% | 12.1% | ||
| Q1 24 | 98.6% | 12.4% |
每股收益（稀释后）BKOGN
| Q4 25 | $2.01 | $-0.78 | ||
| Q3 25 | $1.88 | $0.61 | ||
| Q2 25 | $1.93 | $0.56 | ||
| Q1 25 | $1.58 | $0.33 | ||
| Q4 24 | $1.53 | $0.42 | ||
| Q3 24 | $1.50 | $1.38 | ||
| Q2 24 | $1.52 | $0.75 | ||
| Q1 24 | $1.25 | $0.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1B | $574.0M |
| 总债务越低越好 | $31.9B | $8.6B |
| 股东权益账面价值 | $44.3B | $752.0M |
| 总资产 | $472.3B | $12.9B |
| 负债/权益比越低杠杆越低 | 0.72× | 11.49× |
8季度趋势，按日历期对齐
现金及短期投资BKOGN
| Q4 25 | $5.1B | $574.0M | ||
| Q3 25 | $5.1B | $672.0M | ||
| Q2 25 | $5.7B | $599.0M | ||
| Q1 25 | $5.4B | $547.0M | ||
| Q4 24 | $4.2B | $675.0M | ||
| Q3 24 | $6.2B | $763.0M | ||
| Q2 24 | $5.3B | $704.0M | ||
| Q1 24 | $5.3B | $575.0M |
总债务BKOGN
| Q4 25 | $31.9B | $8.6B | ||
| Q3 25 | $32.3B | $8.8B | ||
| Q2 25 | $33.4B | $8.9B | ||
| Q1 25 | $30.9B | $9.0B | ||
| Q4 24 | $30.9B | $8.9B | ||
| Q3 24 | $33.2B | $8.7B | ||
| Q2 24 | $30.9B | $8.7B | ||
| Q1 24 | $32.4B | $8.7B |
股东权益BKOGN
| Q4 25 | $44.3B | $752.0M | ||
| Q3 25 | $43.9B | $906.0M | ||
| Q2 25 | $44.0B | $733.0M | ||
| Q1 25 | $43.1B | $542.0M | ||
| Q4 24 | $41.3B | $472.0M | ||
| Q3 24 | $42.0B | $493.0M | ||
| Q2 24 | $40.8B | $144.0M | ||
| Q1 24 | $40.6B | $48.0M |
总资产BKOGN
| Q4 25 | $472.3B | $12.9B | ||
| Q3 25 | $455.3B | $13.6B | ||
| Q2 25 | $485.8B | $13.5B | ||
| Q1 25 | $440.7B | $13.2B | ||
| Q4 24 | $416.1B | $13.1B | ||
| Q3 24 | $427.5B | $12.8B | ||
| Q2 24 | $428.5B | $12.2B | ||
| Q1 24 | $434.7B | $11.9B |
负债/权益比BKOGN
| Q4 25 | 0.72× | 11.49× | ||
| Q3 25 | 0.74× | 9.74× | ||
| Q2 25 | 0.76× | 12.14× | ||
| Q1 25 | 0.72× | 16.52× | ||
| Q4 24 | 0.75× | 18.81× | ||
| Q3 24 | 0.79× | 17.75× | ||
| Q2 24 | 0.76× | 60.11× | ||
| Q1 24 | 0.80× | 181.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $141.0M |
| 自由现金流经营现金流 - 资本支出 | $4.7B | $96.0M |
| 自由现金流率自由现金流/营收 | 352.8% | 6.4% |
| 资本支出强度资本支出/营收 | 32.4% | 3.0% |
| 现金转化率经营现金流/净利润 | 3.55× | — |
| 过去12个月自由现金流最近4个季度 | $5.2B | $538.0M |
8季度趋势，按日历期对齐
经营现金流BKOGN
| Q4 25 | $5.2B | $141.0M | ||
| Q3 25 | $-1.1B | $264.0M | ||
| Q2 25 | $2.2B | $220.0M | ||
| Q1 25 | $412.0M | $75.0M | ||
| Q4 24 | $1.6B | $390.0M | ||
| Q3 24 | $-312.0M | $141.0M | ||
| Q2 24 | $2.1B | $332.0M | ||
| Q1 24 | $-2.7B | $76.0M |
自由现金流BKOGN
| Q4 25 | $4.7B | $96.0M | ||
| Q3 25 | $-1.5B | $218.0M | ||
| Q2 25 | $1.8B | $181.0M | ||
| Q1 25 | $92.0M | $43.0M | ||
| Q4 24 | $1.1B | $335.0M | ||
| Q3 24 | $-687.0M | $99.0M | ||
| Q2 24 | $1.7B | $300.0M | ||
| Q1 24 | $-3.0B | $30.0M |
自由现金流率BKOGN
| Q4 25 | 352.8% | 6.4% | ||
| Q3 25 | -121.5% | 13.6% | ||
| Q2 25 | 152.8% | 11.4% | ||
| Q1 25 | 7.9% | 2.8% | ||
| Q4 24 | 95.2% | 21.0% | ||
| Q3 24 | -65.6% | 6.3% | ||
| Q2 24 | 169.6% | 18.7% | ||
| Q1 24 | -286.4% | 1.8% |
资本支出强度BKOGN
| Q4 25 | 32.4% | 3.0% | ||
| Q3 25 | 35.4% | 2.9% | ||
| Q2 25 | 29.8% | 2.4% | ||
| Q1 25 | 27.6% | 2.1% | ||
| Q4 24 | 34.6% | 3.5% | ||
| Q3 24 | 35.8% | 2.7% | ||
| Q2 24 | 37.1% | 2.0% | ||
| Q1 24 | 28.7% | 2.8% |
现金转化率BKOGN
| Q4 25 | 3.55× | — | ||
| Q3 25 | -0.74× | 1.65× | ||
| Q2 25 | 1.54× | 1.52× | ||
| Q1 25 | 0.34× | 0.86× | ||
| Q4 24 | 1.34× | 3.58× | ||
| Q3 24 | -0.26× | 0.39× | ||
| Q2 24 | 1.82× | 1.70× | ||
| Q1 24 | -2.61× | 0.38× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
